NEW YORK (GenomeWeb) – Institut Curie and Intel will collaborate to develop and implement bioinformatics tools, pipelines, and techniques to improve molecular profiling for research and clinical oncology, the partners said today.

As part of the collaboration, Institut Curie will have access to Intel experts to build and optimize a high-performance computing and artificial intelligence infrastructure to implement the Intel Genomics ecosystem, which includes partner solutions and best practices such as pipeline optimization from the Broad Institute for Cancer Genomics.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

British Nobel laureates and Fields Medal winners warn that a 'hard' Brexit could harm science across the UK, the Guardian reports.

Vox reports on inequities in genetic research and efforts to address them.

The New York Times reports that Arizona State University's Lawrence Krauss is retiring following allegations of sexual misconduct.

In PNAS this week: de novo NUS1 mutations linked to Parkinson's disease risk, candidate hepatocellular carcinoma drivers, and more.

Nov
05
Sponsored by
Sophia Genetics

With the Next Generation Sequencing (NGS), genomes sequencing has been democratized over the last decades with the detection of genomic alterations, thus replacing Sanger sequencing.